Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Elon Musk’s brain implant company Neuralink has taken the initiative to start brain chip clinical trials in the United ...

Japan has launched clinical trials for a synthetic, universally compatible blood substitute, marking a potential breakthrough ...

Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have ...

Elon Musk's Neuralink is set to conduct a groundbreaking clinical study in Great Britain to test brain chips that allow patients with severe paralysis to control digital tools with their thoughts.

Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of ...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents.

Neuralink is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study.

Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical ...

CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidate Centauri plans the progression of lead candidate, an immunotherapy based ...

Tulsi Therapeutics achieves groundbreaking success in animal trial for liver disease treatment, paving way for human trials.

The new drug forces fat cells to produce more energy and doesn't impact appetite or muscle mass, unlike some existing ...